Category:Template-Class pharmacology articles
Appearance
This category is located at Category:Template-Class pharmacology pages.
Note: This category should be empty.
See the instructions for more information. |
Pages in category "Template-Class pharmacology articles"
The following 136 pages are in this category, out of 136 total. This list may not reflect recent changes.
A
- Template talk:Appetite stimulants
- Template talk:Aryl hydrocarbon receptor modulators
- Template talk:ATC code D
- Template talk:ATC code H
- Template talk:ATC code J
- Template talk:ATC code L
- Template talk:ATC code M
- Template talk:ATC code P
- Template talk:ATC codes short
- Template talk:Available forms of testosterone
C
G
- Template talk:GH/IGF-1 axis signaling modulators
- Template talk:Glucocorticoid activity of selected steroids in vitro
- Template talk:Glucocorticoid receptor modulators
- Template talk:Glucocorticoids and antiglucocorticoids
- Template talk:GnRH and gonadotropin receptor modulators
- Template talk:Growth factor receptor modulators
H
- Template talk:Herbs used as laxatives
- Template talk:Histone deacetylase inhibitors
- Template talk:Hormone levels with gonadotropin-releasing hormone agonists and antagonists
- Template talk:Hormone levels with nandrolone esters by intramuscular injection
- Template talk:Hormone levels with sublingual estradiol
I
- Template talk:IC50
- Template talk:Illegal-drug-trade-stub
- Template talk:Imidazoline receptor modulators
- Template talk:Infobox receptor
- Template talk:Insomnia medications
- Template talk:Interleukin receptor modulators
- Template talk:Ion channel modulators
- Template talk:Ionotropic glutamate receptor modulators
- Template talk:IUPHAR chapter
L
M
- Template talk:Medical citation needed span
- Template talk:MEDRS evaluation
- Template talk:Melanocortin receptor modulators
- Template talk:Mineral supplements
- Template talk:Mineralocorticoid receptor modulators
- Template talk:Mineralocorticoids and antimineralocorticoids
- Template talk:Monoamine metabolism modulators
- Template talk:Monoamine neurotoxins
- Template talk:Monoamine releasing agents
- Template talk:Monoamine reuptake inhibitors
- Template talk:Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems
N
O
- Template talk:Obstetric drugs
- Template talk:OCD pharmacotherapies
- Template talk:Oral potencies of progestogens
- Template talk:Orexin receptor modulators
- Template talk:Other drugs for disorders of the musculo-skeletal system
- Template talk:Other hematological agents
- Template talk:Oxytocin and vasopressin receptor modulators
P
- Template talk:PAF receptor modulators
- Template talk:Parenteral durations of androgens/anabolic steroids
- Template talk:Parenteral potencies and durations of nonsteroidal estrogens
- Template talk:Parenteral potencies and durations of progestogens
- Template talk:Pharmaceutical industry in the United States
- Template talk:Pharmacodynamics of progestogens
- Template talk:Pharmacokinetics of 100 mg per day spironolactone and its metabolites
- Template talk:Pharmacokinetics of long-acting injectable antipsychotics
- Template talk:Pharmacokinetics of progestogens
- Template talk:Pharmacokinetics of three estradiol esters by intramuscular injection
- Template talk:Pharmacological properties of major anabolic steroids
- Template talk:Pharmacology of estrone
- Template talk:Pharmacology-journal-stub
- Template talk:PharmNavFootnote
- Template talk:Pheromones and pherines
- Template talk:Plasma estrogen levels after a single dose of conjugated estrogens by different routes
- Template talk:Plasma estrogen levels after a single dose of estradiol by different routes
- Template talk:Plasma levels and binding potential of flutamide and bicalutamide during first week
- Template talk:Potencies and durations of natural estrogens by intramuscular injection
- Template talk:PPAR modulators
- Template talk:Progesterone receptor modulators
- Template talk:Prolactin receptor modulators
- Template talk:Prostanoid signaling modulators
- Template talk:Protein binding and metabolic clearance rates of estrogens
- Template talk:Psychoactive-stub
- Template talk:Published case reports of bicalutamide-associated liver injury
- Template talk:Published case reports of bicalutamide-associated lung toxicity
- Template talk:Purine receptor modulators
R
- Template talk:Recent changes in Pharmacology
- Template talk:Receptor modulators
- Template talk:Relative affinities of anabolic steroids and related steroids
- Template talk:Relative affinities of hydroxyprogesterone and related steroids
- Template talk:Relative affinities of nandrolone and related steroids
- Template talk:Relative affinities of nandrolone and related steroids at the androgen receptor
- Template talk:Relative affinities of norethisterone, metabolites, and prodrugs
- Template talk:Relative affinities of noretynodrel, tibolone, and metabolites
- Template talk:Relative affinities of normethandrone and metabolites
- Template talk:Relative androgenic to anabolic activity in animals
- Template talk:Relative oral potencies of estrogens
- Template talk:Relative potencies of selected antiandrogens
- Template talk:Retinoid receptor modulators
S
- Template talk:Selected biological properties of endogenous estrogens in rats
- Template talk:Side effects of estramustine phosphate (EMC)
- Template talk:Side effects of estramustine phosphate (FDA)
- Template talk:Side effects of estrogen plus high- versus low-dose cyproterone acetate in women
- Template talk:Sodium-glucose transporter modulators
- Template talk:Spironolactone
- Template talk:Spironolactone at steroid hormone receptors
- Template talk:Steroid hormones
- Template talk:Structural aspects of androgens and anabolic steroids
- Template talk:Structural aspects of progestogens used in clinical and veterinary medicine
- Template talk:Structural properties of major anabolic steroid esters
- Template talk:Structural properties of major testosterone esters
- Template talk:Structural properties of selected estradiol esters
- Template talk:Symporter inhibitors
T
- Template talk:Target ranges for hormone levels in hormone therapy for transgender women
- Template talk:Testosterone
- Template talk:Testosterone levels with cyproterone acetate
- Template talk:TGFβ receptor superfamily modulators
- Template talk:The Pharmacology Barnstar
- Template talk:Thyroid hormone receptor modulators
- Template talk:Timothy Leary
- Template talk:Tissue-specific estrogenic and antiestrogenic activity of SERMs
- Template talk:TNF receptor superfamily modulators
- Template talk:Transdermal estradiol patches marketed in the United States
- Template talk:Translocator protein modulators